Stock Track | TRANSTHERA-B Plummets 5.22% in Pre-Market After Announcing Private Placement at 18% Discount

Stock Track09:37

TRANSTHERA-B's stock plummeted 5.22% in pre-market trading on Tuesday, following the company's announcement of a private placement of shares at a significant discount to the previous closing price.

The biopharmaceutical company revealed plans to place approximately 3.836 million new H shares at HK$40.83 per share, representing an 18.01% discount to Monday's closing price of HK$49.80. The placement is expected to raise gross proceeds of approximately HK$157 million, with net proceeds estimated at around HK$152 million after deducting commissions and expenses.

Approximately 90% of the net proceeds from the placement are earmarked for developing new indications for the company's core product, Tinengotinib, with the remaining 10% allocated for working capital and general corporate purposes. The placement shares represent approximately 0.95% of the company's existing issued shares and are expected to be issued subject to listing approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment